Dyslipidemia in diabetes is a common and clinically significant metabolic abnormality that substantially increases cardiovascular risk. It is typically characterized by elevated triglycerides, reduced HDL cholesterol, and the presence of small dense LDL particles, even when LDL levels appear normal. Insulin resistance plays a central role in its pathophysiology. Early detection and comprehensive lipid management are essential in reducing macrovascular complications and improving long-term outcomes in patients with diabetes. Gain in-depth insights into the latest developments in managing dyslipidemia in patients with diabetes from renowned Internal Medicine specialist Dr.
Urman A. Dhruv in an insightful session on May 25 , 2026 , at 3:00 PM IST . Stay tuned! ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy,…
